Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Trinity Biotech buys Fiomi Diagnostics for $13.1mm in cash, stock, and earn-outs

Executive Summary

Trinity Biotech PLC (point-of-care and clinical laboratory diagnostics) has acquired Fiomi Diagnostics AB for $13.1mm, with $9.7mm up front ($5.6mm will be in cash and $4.1mm in 408k Trinity Biotech ADRs) and $3.4mm in earn-outs (for getting the CE Mark, FDA submission, and FDA approval of a troponin I assay).
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies